newsfilter
← Latest News
Business Wire·

Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the three